Skip to main content
Impel Pharmaceuticals Inc (IMPLQ)
Apr 5, 2024 - IMPLQ was delisted (reason: shares cancelled)
0.0150
+0.0050 (50.00%)
Last trade price

Impel Pharmaceuticals Revenue

Impel Pharmaceuticals had revenue of $20.99M in the twelve months ending September 30, 2023, with 155.29% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $5.02M with 62.98% year-over-year growth. In the year 2022, Impel Pharmaceuticals had annual revenue of $12.65M with 1,794.01% growth.

Revenue (ttm)
$20.99M
Revenue Growth
+155.29%
P/S Ratio
0.02
Revenue / Employee
$131,169
Employees
160
Market Cap
356.24K USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202212.65M11.98M1,794.01%
Dec 31, 2021668.00K--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

IMPLQ News

More News